KoshKey

KoshKey Sciences Pvt Ltd is a pioneering brand specializing in therapies for cellular reprogramming. With a focus on tackling the global issue of antibiotic resistance, KoshKey is developing a groundbreaking therapy that can effectively clear antimicrobial resistant (AMR) infections while promoting wound healing. Amidst the alarming rise of antibiotic-resistant bacterial infections, KoshKey recognizes the urgent need for novel approaches.

In 2019 alone, nearly 4. 95 million deaths were attributed to bacterial AMR, and this number could surpass 10 million annually by 2050 without effective interventions. Those at higher risk include individuals with weakened immunity and exposure to healthcare-associated infections, such as diabetic patients.

With a high prevalence of type-II diabetes, India particularly experiences a significant burden of non-healing wounds and bacterial infections among the elderly diabetic population. To combat this growing problem, KoshKey's innovative therapy delves into the molecular mechanisms underlying why diabetic skin cells struggle to initiate wound healing and fight off infections. Leveraging their unique RNA interference technology, they activate the healthy wound-healing program and the body's antimicrobial response in skin keratinocytes.

This dual-action approach aims to achieve pathogen clearance and accelerate wound healing. Choose KoshKey for cutting-edge therapies that address the pressing challenges of antibiotic resistance and non-healing wounds